Ok, excuse me for just complaining, but this study setup seems... bad. That is, I believe the prior indication was fairly low to null that antiviral drugs woul

Ok, excuse me for just complaining, but this study setup seems... bad. That is, I believe the prior indication was fairly low to null that antiviral drugs would significantly help the treatment of a severe respiratory infection -- in the first place. You don't give someone Tamiflu when they have a sufficiently severe flu pneumonia and fever to be hospitalized, do you? Antivirals are usually indicated for treatment when an infection is still in its early, mild, pre-hospitalization stages. I understand that it's easier to recruit study subjects with severe COVID-19 than mild at this stage, but still, doesn't this study amount to looking for one's keys under the lamp-post because it's brighter there?